"My parent has turned 65, but should they get the pneumococcal vaccine?""Since they are already over 70, are they ineligible ...

Prescriptions Written by a Pediatric Specialist —Fever, colds, infectious diseases, vaccinations, skin problems, ...

The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older. The vaccine, which will be sold under the name Capvaxive, is designed to protect against ...

The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday. "Lowering the ...

Oct 5 (Reuters) - Vaxcyte said on Monday its experimental pneumococcal vaccine met its main goals in a late-stage study in adults aged 50 and older, sending its shares up 91% before the bell. Here are ...

Please provide your email address to receive an email when new articles are posted on . Researchers compared the 21-valent vaccine to a combination of a 15-valent and 23-valent vaccines. Fewer adverse ...

The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer and Merck on nearly all bacterial strains in the first of three Phase 3 ...

We alerted readers to PCVX on October 27, 2025, when it was at $42.30. The stock gathered pace over successive months, ...

Pneumococcal disease is an infection caused by bacteria known as pneumococcus (Streptococcus pneumoniae). The most common infections from this bacteria are lung infection (pneumonia), bloodstream ...

Key TakeawaysVaxcyte shares are up about 36% after its VAX-31 pneumococcal vaccine met every primary goal in OPUS-1, its ...

The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. This vaccine replaces previously listed pneumococcal ...